In conclusion, SA bacteremic patients had increased frequency of CD4+CD161+ T cells compared to healthy controls suggesting that type II NKT cells could be relevant in the human setting for combatting SA bacteremia. This evidence concerns the gene KLRB1 and bacterial infectious disease with sepsis.